Colorectal Neoplasms Clinical Trial
Official title:
A Randomized Controlled Trial of Preoperative Carbohydrate Drinks on Postoperative Walking Capacity in Colorectal Surgery.
This prospective randomized controlled study is designed to investigate whether preoperative oral carbohydrate loading improves postoperative walking performance, a surrogate indicator for overall functional recovery, in patients undergoing colorectal surgery as measured by 2-minute and 6-minute walk test. The secondary outcomes are postoperative insulin resistance measured with plasma insulin and glucose concentrations. The tertiary outcomes are duration of hospital stay, patients satisfaction during staying in the hospital and morbidity measured as postoperative complications.
After approval by the Siriraj Institutional Review Board, patients aged greater than 18 years
undergoing elective colorectal surgery at Siriraj Hospital will be approached and recruited
in this study. Exclusion criteria are diabetes mellitus, any endocrine disorders or metabolic
abnormalities, impaired renal function (GFR <60 ml/min), impaired hepatic function
(Child-Pugh score class C), a history of delayed gastric emptying time, body mass index >30,
inability to communicate and severe physical disability. Informed written consent will be
obtained from each subject.
At the time of admission to the hospital, patients will be randomly allocated to one of the
two groups using a computer-generated randomization schedule in a block of five. The
carbohydrate (CHO) group will be given the carbohydrate drink (12.5% carbohydrates, 50
kcal/100 ml, 240 mOsmol/l, pH 5.0) while the control group will be given pure water. The
pharmacy department is responsible for preparing the carbohydrate drink. The patients in the
two groups will be given 800 mL of one of the drinks the night before surgery, between 1900
and 2400 h, and another 400 ml in the morning of the operation day. The last drink will be no
later than 3 hours before the scheduled induction of anesthesia. Of note, the last meal on
the day before the operation will be no later than 1800 h. Following this meal, no food or
drink will be allowed except the carbohydrate drink or pure water.
Before induction of anesthesia, a thoracic epidural catheter will be inserted as routine in
either the ninth or tenth thoracic intervertebral space in patients undergoing laparotomy
colorectal surgery. Lidocaine 2% with epinephrine 1:200,000 3 mL will be injected in the
epidural space to produce a bilateral segmental sensory block to ice and pinprick between T6
and T12 dermatomes. The neural blockade was maintained during surgery with additional
infusion of bupivacaine 0.25% 4-8 mL/h.
General anesthesia will be induced in all patients with same protocol. Preoperative
mechanical bowel preparation will be utilized in the case of left-sided colon cancer or
rectal cancer. Intravenous prophylactic antibiotics will be administered to every patient.
All operations will be performed by well-experienced surgeons. The choice of incision and
operation will depend on tumor location and surgeon's discretion.
Primary outcomes are 2-minute walk test (2MWT) which will be measured before surgery to be a
baseline, and then 2MWT will be measured at 72 hours after surgery. Patients will be asked to
walk back and forth along a 15 m stretch of hallway as much as they can over a period of 2
minutes. To ensure safety, the evaluator walks behind the patient. Patients are told that
they can rest if necessary, and they are allowed to use their regular walking aids.
Serum insulin and glucose concentrations will be measured preoperatively, and on the first
three postoperative days. Blood sample for insulin will be centrifuged (Cobas® 8000 modular
analyzer series; modular pre-analytics evo, Roche) at 3000 rpm for 5 min at 22.5°C and
insulin level will be measured by a two-site immunoassay using electrochemiluminescence
immunoassay (ECLIA) (Cobas® 8000 modular analyzer series: e 602 module, Roche). Blood sample
for glucose will be immediately centrifuged (Kokusan H-28F, Euroscan) at 3500 rpm for 10 min
at 25°C and glucose concentration will be measured using an enzymatic (Hexokinase) method
(Cobas integra® 800 analyzer; c 702 module, Roche).
24-Hour urine urea nitrogen will be measured on the first three postoperative days. The urine
sample will be centrifuged (Cobas® 8000 modular analyzer series; modular pre-analytics evo,
Roche) at 3000 rpm for 5 min at 22.5°C and measured using a urease/glutamate dehydrogenase
coupled enzymatic technique (Cobas 8000 modular analyzer series: c 702 module, Roche).
Postoperative pain at rest and on mobilization at postoperative 24, 48 and 72 hours will be
assessed with verbal rating score (VRS) from 0 (no pain) to 10 (worst pain). Postoperative
use of analgesics and amount of analgesic medication will be recorded daily during the first
three postoperative days. The duration of hospital stay will be measured by time (days) from
the day of surgery to the day of discharge. Patient satisfaction during staying in the
hospital will be assessed when discharging from the hospital with a verbal rating score
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04552093 -
Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT)
|
Phase 2/Phase 3 | |
Completed |
NCT04192565 -
A Prospective Investigation of the ColubrisMX ELS System
|
N/A | |
Completed |
NCT05178745 -
A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
|
||
Recruiting |
NCT03561350 -
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
|
||
Recruiting |
NCT06128798 -
Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.
|
N/A | |
Recruiting |
NCT03602677 -
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage
|
N/A | |
Completed |
NCT03631407 -
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)
|
Phase 2 | |
Withdrawn |
NCT04192929 -
Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy
|
N/A | |
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Terminated |
NCT02842580 -
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer
|
Phase 2 | |
Completed |
NCT02889679 -
Underwater Resection of Non-pedunculated Colorectal Lesions
|
N/A | |
Completed |
NCT02564835 -
Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer
|
N/A | |
Completed |
NCT02149108 -
Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)
|
Phase 3 | |
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT02599103 -
The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects
|
N/A | |
Completed |
NCT01669109 -
Hatha Yoga for Patients With Colorectal Cancer
|
N/A | |
Completed |
NCT01719926 -
Phase I Platinum Based Chemotherapy Plus Indomethacin
|
Phase 1 | |
Recruiting |
NCT01428752 -
Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal Cancer
|
N/A | |
Completed |
NCT01978717 -
General Anesthesia Combined With Epidural Anesthesia Mitigates the Surgical Stress-related Immunosuppression in Patients With Colorectal Cancer
|
N/A | |
Completed |
NCT01877018 -
Colorectal Cancer Screening in Primary Care
|
N/A |